Foster Dykema Cabot & Partners’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.17M Buy
16,848
+10,375
+160% +$2.2M 0.17% 36
2026
Q2
$1.35M Hold
6,473
– – 0.08% 41
2026
Q1
$1.07M Hold
6,473
– – 0.07% 46
2025
Q4
$1.15M Sell
6,473
-219
-3% -$36.5K 0.07% 43
2025
Q3
$1.06M Buy
6,692
+236
+4% +$34.8K 0.07% 52
2025
Q2
$909K Buy
6,456
+1,037
+19% +$127K 0.06% 53
2025
Q1
$632K Sell
5,419
-43
-0.8% -$5.54K 0.05% 66
2024
Q4
$687K Hold
5,462
– – 0.05% 67
2024
Q3
$569K Buy
5,462
+494
+10% +$49.7K 0.05% 72
2024
Q2
$483K Hold
4,968
– – 0.04% 64
2024
Q1
$468K Hold
4,968
– – 0.04% 66
2023
Q4
$463K Buy
+4,968
New +$397K 0.05% 61

Other funds holding MS

Foster Dykema Cabot & Partners's MS Position: Q3 2026 in Review

Foster Dykema Cabot & Partners increased its Morgan Stanley (MS) stake by 160% in Q3 2026, buying an estimated $2.2M and bringing the position to 16,848 shares worth $3.17M. The position accounts for 0.17% of the portfolio, ranked #36.

Foster Dykema Cabot & Partners first reported a position in MS in Q4 2023 and has held it in 12 quarters since. 2,687 funds tracked by Wall St. Rank hold MS as of Q3 2026.

  • Foster Dykema Cabot & Partners held 16,848 shares of Morgan Stanley worth $3.17M as of Q3 2026.
  • Foster Dykema Cabot & Partners bought 10,375 Morgan Stanley shares in Q3 2026, an estimated $2.2M.
  • Morgan Stanley made up 0.17% of Foster Dykema Cabot & Partners's portfolio in Q3 2026, its #36 holding.
  • Foster Dykema Cabot & Partners first reported a position in Morgan Stanley in Q4 2023 and has held it in 12 quarters since.
  • 2,687 funds tracked by Wall St. Rank held Morgan Stanley as of Q3 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q3 2026, filed 30 Oct 2026.